Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: OLINK PROTEOMICS AB
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-19 to 2024-07-18
Current total value of award: $63492
Description: THE NCI PROPOSES TO TEST 440 SAMPLES USING THE OLINK TARGET 96 INFLAMMATION PANEL